Combined use of platelet serotonergic markers and psychopathological scales as diagnostic screening of a psychotic versus a depressive disorder.
A single case of a patient suffering from a first psychotic episode and the differential diagnoses between affective and psychosis is performed throughout the combined use of peripheral serotonergic markers and clinical psychopathological scales during a 6-months follow-up. The results suggest the need of performing further studies combining biological and clinical markers of psychiatric disorders.
Ramirez
Nicolas
N
Benito Menni, CASM, Hospital de Granollers, Mental Health Care Institute, Avda. Francesc Ribas s/n, 08400 Granollers, Barcelona, Spain. 32698nrn@comb.es
Arranz
Belén
B
Martín
Carmen
C
San
Luis
L
D000328:Adult; D015415:Biomarkers; D001792:Blood Platelets / Q000378:metabolism; D003866:Depressive Disorder / Q000097:blood* / Q000175:diagnosis* / Q000523:psychology; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D011581:Psychological Tests; D011618:Psychotic Disorders / Q000097:blood* / Q000175:diagnosis* / Q000523:psychology; D012701:Serotonin / Q000097:blood* / Q000378:metabolism; D012720:Severity of Illness Index
D015415:Biomarkers; D012701:Serotonin